BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38043191)

  • 21. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-specificity RNA aptamers enable manipulation of target-specific O-GlcNAcylation and unveil functions of O-GlcNAc on β-catenin.
    Zhu Y; Hart GW
    Cell; 2023 Jan; 186(2):428-445.e27. PubMed ID: 36626902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of O-GlcNAc in chronic diseases of aging.
    Banerjee PS; Lagerlöf O; Hart GW
    Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells.
    Zafir A; Bradley JA; Long BW; Muthusamy S; Li Q; Hill BG; Wysoczynski M; Prabhu SD; Bhatnagar A; Bolli R; Jones SP
    PLoS One; 2015; 10(11):e0142939. PubMed ID: 26565625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutrient regulation of the flow of genetic information by O-GlcNAcylation.
    Zhu Y; Hart GW
    Biochem Soc Trans; 2021 Apr; 49(2):867-880. PubMed ID: 33769449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    Du P; Zhang X; Lian X; Hölscher C; Xue G
    J Alzheimers Dis; 2024; 97(3):1051-1068. PubMed ID: 38250776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
    Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
    Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of cancer metabolism by O-GlcNAcylation.
    Li Z; Yi W
    Glycoconj J; 2014 Apr; 31(3):185-91. PubMed ID: 24323367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
    Le Minh G; Reginato MJ
    Adv Cancer Res; 2023; 157():195-228. PubMed ID: 36725109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenum.
    Ostrowski A; Gundogdu M; Ferenbach AT; Lebedev AA; van Aalten DM
    J Biol Chem; 2015 Dec; 290(51):30291-305. PubMed ID: 26491011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical and Biochemical Perspectives of Protein O-GlcNAcylation.
    Ma J; Wu C; Hart GW
    Chem Rev; 2021 Feb; 121(3):1513-1581. PubMed ID: 33416322
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Xu Z; Isaji T; Fukuda T; Wang Y; Gu J
    J Biol Chem; 2019 Mar; 294(9):3117-3124. PubMed ID: 30587575
    [No Abstract]   [Full Text] [Related]  

  • 33. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
    Ogawa M; Sawaguchi S; Kamemura K; Okajima T
    Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues.
    Chen L; Hu M; Chen L; Peng Y; Zhang C; Wang X; Li X; Yao Y; Song Q; Li J; Pei H
    Cancer Lett; 2024 Apr; 588():216742. PubMed ID: 38401884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Zhang Z; Parker MP; Graw S; Novikova LV; Fedosyuk H; Fontes JD; Koestler DC; Peterson KR; Slawson C
    J Biol Chem; 2019 Jan; 294(4):1363-1379. PubMed ID: 30523150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis.
    Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J
    FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
    Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
    Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition.
    Drougat L; Olivier-Van Stichelen S; Mortuaire M; Foulquier F; Lacoste AS; Michalski JC; Lefebvre T; Vercoutter-Edouart AS
    Biochim Biophys Acta; 2012 Dec; 1820(12):1839-48. PubMed ID: 22967762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.